BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

755 related articles for article (PubMed ID: 28939743)

  • 21. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
    Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
    Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-proliferative effect of atrial natriuretic peptide on colorectal cancer cells: evidence for an Akt-mediated cross-talk between NHE-1 activity and Wnt/β-catenin signaling.
    Serafino A; Moroni N; Psaila R; Zonfrillo M; Andreola F; Wannenes F; Mercuri L; Rasi G; Pierimarchi P
    Biochim Biophys Acta; 2012 Jun; 1822(6):1004-18. PubMed ID: 22387884
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apicidin-resistant HA22T hepatocellular carcinoma cells strongly activated the Wnt/β-catenin signaling pathway and MMP-2 expression via the IGF-IR/PI3K/Akt signaling pathway enhancing cell metastatic effect.
    Hsieh CH; Cheng LH; Hsu HH; Ho TJ; Tu CC; Lin YM; Chen MC; Tsai FJ; Hsieh YL; Huang CY
    Biosci Biotechnol Biochem; 2013; 77(12):2397-404. PubMed ID: 24317053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Beta-catenin/Tcf-4 inhibition after progastrin targeting reduces growth and drives differentiation of intestinal tumors.
    Pannequin J; Delaunay N; Buchert M; Surrel F; Bourgaux JF; Ryan J; Boireau S; Coelho J; Pélegrin A; Singh P; Shulkes A; Yim M; Baldwin GS; Pignodel C; Lambeau G; Jay P; Joubert D; Hollande F
    Gastroenterology; 2007 Nov; 133(5):1554-68. PubMed ID: 17920061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation.
    Al-Dhfyan A; Alhoshani A; Korashy HM
    Mol Cancer; 2017 Jan; 16(1):14. PubMed ID: 28103884
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maintenance of adenomatous polyposis coli (APC)-mutant colorectal cancer is dependent on Wnt/beta-catenin signaling.
    Scholer-Dahirel A; Schlabach MR; Loo A; Bagdasarian L; Meyer R; Guo R; Woolfenden S; Yu KK; Markovits J; Killary K; Sonkin D; Yao YM; Warmuth M; Sellers WR; Schlegel R; Stegmeier F; Mosher RE; McLaughlin ME
    Proc Natl Acad Sci U S A; 2011 Oct; 108(41):17135-40. PubMed ID: 21949247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the Wnt/β-catenin and RAS-ERK pathways involving co-stabilization of both β-catenin and RAS plays important roles in the colorectal tumorigenesis.
    Lee SK; Hwang JH; Choi KY
    Adv Biol Regul; 2018 May; 68():46-54. PubMed ID: 29449169
    [TBL] [Abstract][Full Text] [Related]  

  • 29. E2F1 suppresses Wnt/β-catenin activity through transactivation of β-catenin interacting protein ICAT.
    Wu Z; Zheng S; Li Z; Tan J; Yu Q
    Oncogene; 2011 Sep; 30(37):3979-84. PubMed ID: 21532622
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Molecular mechanisms of resistance to phosphatidyl inositol 3-kinase inhibitors in triple-negative breast cancer cells].
    Zhang WL; Ma WJ; Chen S; Wu XZ; Zhang HR; Zhang JH
    Zhonghua Zhong Liu Za Zhi; 2016 Aug; 38(8):578-88. PubMed ID: 27531477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of PI3K/AKT signaling inhibits glioma cell growth through modulation of β-catenin-mediated transcription.
    Han L; Yang Y; Yue X; Huang K; Liu X; Pu P; Jiang H; Yan W; Jiang T; Kang C
    Brain Res; 2010 Dec; 1366():9-17. PubMed ID: 20888802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PI3K is required for the physical interaction and functional inhibition of NF-κB by β-catenin in colorectal cancer cells.
    Liu J; Liao Y; Ma K; Wang Y; Zhang G; Yang R; Deng J
    Biochem Biophys Res Commun; 2013 May; 434(4):760-6. PubMed ID: 23583404
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of ICAT as an APC Inhibitor, Revealing Wnt-Dependent Inhibition of APC-Axin Interaction.
    Ji L; Lu B; Wang Z; Yang Z; Reece-Hoyes J; Russ C; Xu W; Cong F
    Mol Cell; 2018 Oct; 72(1):37-47.e4. PubMed ID: 30197296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ICAT inhibits glioblastoma cell proliferation by suppressing Wnt/β-catenin activity.
    Zhang K; Zhu S; Liu Y; Dong X; Shi Z; Zhang A; Liu C; Chen L; Wei J; Pu P; Zhang J; Jiang T; Han L; Kang C
    Cancer Lett; 2015 Feb; 357(1):404-411. PubMed ID: 25434796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. All Trans-Retinoic Acid Mediates MED28/HMG Box-Containing Protein 1 (HBP1)/β-Catenin Signaling in Human Colorectal Cancer Cells.
    Lee MF; Hsieh NT; Huang CY; Li CI
    J Cell Physiol; 2016 Aug; 231(8):1796-803. PubMed ID: 26660958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Wnt/β-Catenin Pathway Activation Mediates Adaptive Resistance to BRAF Inhibition in Colorectal Cancer.
    Chen G; Gao C; Gao X; Zhang DH; Kuan SF; Burns TF; Hu J
    Mol Cancer Ther; 2018 Apr; 17(4):806-813. PubMed ID: 29167314
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Scutellaria barbata D. Don inhibits colorectal cancer growth via suppression of Wnt/β-catenin signaling pathway.
    Wei LH; Lin JM; Chu JF; Chen HW; Li QY; Peng J
    Chin J Integr Med; 2017 Nov; 23(11):858-863. PubMed ID: 29080197
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knockdown of CXCR4 Inhibits CXCL12-Induced Angiogenesis in HUVECs through Downregulation of the MAPK/ERK and PI3K/AKT and the Wnt/β-Catenin Pathways.
    Song ZY; Wang F; Cui SX; Qu XJ
    Cancer Invest; 2018 Jan; 36(1):10-18. PubMed ID: 29381400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.